Contact Us

Merck & Co., Inc. announced a voluntary withdrawal of Vioxx (rofecoxib) from the U.S. and worldwide market due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients on Vioxx. Vioxx is a prescription COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) that was approved by FDA in May 1999 for the relief of the signs and symptoms of osteoarthritis, for the management of acute pain in adults, and for the treatment of menstrual symptoms. Vioxx was later approved for the relief of the signs and symptoms of rheumatoid arthritis in adults and children.

• Alabama Vioxx Law
• Alaska Vioxx Law
• Arizona Vioxx Law
• Arkansas Vioxx Law
• California Vioxx Law
• Colorado Vioxx Law
• Connecticut Vioxx Law
• Delaware Vioxx Law
• District Of Columbia Vioxx Law
• Florida Vioxx Law
• Georgia Vioxx Law
• Hawaii Vioxx Law
• Idaho Vioxx Law
• Illinois Vioxx Law
• Indiana Vioxx Law
• Iowa Vioxx Law
• Kansas Vioxx Law
• Kentucky Vioxx Law
• Louisiana Vioxx Law
• Maine Vioxx Law
• Marshall Islands Vioxx Law
• Maryland Vioxx Law
• Massachusetts Vioxx Law
• Michigan Vioxx Law
• Minnesota Vioxx Law
• Mississippi Vioxx Law
• Missouri Vioxx Law
• Montana Vioxx Law
• Nebraska Vioxx Law
• Nevada Vioxx Law
• New Hampshire Vioxx Law
• New Jersey Vioxx Law
• New Mexico Vioxx Law
• New York Vioxx Law
• North Carolina Vioxx Law
• North Dakota Vioxx Law
• Northern Mariana Islands Vioxx Law
• Ohio Vioxx Law
• Oklahoma Vioxx Law
• Oregon Vioxx Law
• Pennsylvania Vioxx Law
• Rhode Island Vioxx Law
• South Carolina Vioxx Law
• South Dakota Vioxx Law
• Tennessee Vioxx Law
• Texas Vioxx Law
• Utah Vioxx Law
• Vermont Vioxx Law
• Virgin Islands Vioxx Law
• Virginia Vioxx Law
• Washington Vioxx Law
• West Virginia Vioxx Law
• Wisconsin Vioxx Law
• Wyoming Vioxx Law